Lemaitre Vascular INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Director Lawrence J. Jasinski reported the acquisition of dividend equivalent rights on existing equity awards.
NASDAQ
Director John James O'Connor reported the accrual of dividend equivalent rights related to existing equity awards.
NASDAQ
Director John A. Roush reported the accrual of dividend equivalent rights on existing equity awards.
NASDAQ
Director Martha Shadan of LeMaitre Vascular, Inc. reported the acquisition of dividend equivalent rights related to existing equity awards.
NASDAQ
Director Joseph P. Pellegrino Jr. acquired additional dividend equivalent rights related to existing equity awards.
NASDAQ
CFO Dorian Paul LeBlanc acquired additional dividend equivalent rights related to existing restricted stock unit awards.
NASDAQ
President and Director David B. Roberts reported the accrual of dividend equivalent rights on existing equity awards.
NASDAQ
Senior VP Trent G. Kamke reported the accrual of dividend equivalent rights related to existing equity awards.
NASDAQ
Chairman and CEO George W. LeMaitre transferred 11,974 shares of common stock to an irrevocable family trust.
NASDAQ
Chairman and CEO George W. LeMaitre sold 46,481 shares of common stock over two days in May 2026.
NASDAQ
Lemaitre Vascular Senior VP of Operations, Trent G. Kamke, sold 2,928 shares of common stock for approximately $107 per share under a pre-arranged trading plan.
NASDAQ
Director Bridget A. Ross reported transactions involving Lematire Vascular Inc. common stock, including option exercises and share disposals.
NASDAQ
Director Lawrence J. Jasinski reported transactions involving Lemaître Vascular Inc. common stock, including option exercises and a sale.
NASDAQ
Director Joseph P. Pellegrino Jr. exercised options to acquire 2,941 shares of LeMaitre Vascular common stock.
NASDAQ
Lemaitre Vascular Director Martha Shadan reported the accrual of dividend equivalent rights tied to previously granted restricted stock and performance share units.
NASDAQ
Lemaitre Vascular Director Bridget A. Ross reported the acquisition of dividend equivalent rights tied to her restricted stock and performance share units.
NASDAQ
Director John James O'Connor of Lemaitre Vascular Inc. reported the accrual of dividend equivalent rights tied to existing equity awards.
NASDAQ
Lemaitre Vascular Director John A. Roush reported the acquisition of dividend equivalent rights tied to previously granted equity awards.
NASDAQ
Lemaitre Vascular Director Lawrence J. Jasinski reported the accrual of dividend equivalent rights tied to his restricted and performance stock unit awards.
NASDAQ
Joseph P. Pellegrino JR, a Director at LEMAITRE VASCULAR INC, reported the acquisition of dividend equivalent rights tied to various equity awards.
NASDAQ
Lemaitre Vascular President and Director David B. Roberts acquired additional dividend equivalent rights tied to his equity awards.
NASDAQ
Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, acquired dividend equivalent rights tied to existing equity awards.
NASDAQ
Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, exercised stock options and subsequently sold the acquired shares.
NASDAQ
Lemaitre Vascular President and Director David B. Roberts sold 3,311.68 shares of common stock on March 11, 2026, at a weighted average price of $107.6752 per share.
NASDAQ
Lemaitre Vascular CFO Dorian Paul LeBlanc reported the acquisition of 2 shares and the disposition of 96 shares for tax withholding related to RSU vesting.
NASDAQ
Lemaitre Vascular Director Martha Shadan acquired 477 shares of common stock through the settlement of a performance share unit award and dividend equivalent rights.
NASDAQ
Lemaitre Vascular Director John Roush acquired 477 shares of common stock through the settlement of a Performance Share Unit award and dividend equivalent rights.
NASDAQ
Lemaitre Vascular Director Bridget A. Ross acquired 477 shares of common stock through the vesting of performance share units and dividend equivalent rights.
NASDAQ
Lemaitre Vascular Director John James O'Connor acquired 477 shares of common stock through the settlement of a performance share unit award and dividend equivalent rights.
NASDAQ
Lemaitre Vascular Director Lawrence J. Jasinski acquired common stock through performance share unit settlement and dividend equivalent rights.